AlphaCrest Capital Management’s Allogene Therapeutics ALLO Stock Holding History

AlphaCrest Capital Management’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$599K	Buy
2022 Q2	$243K	Sell
2022 Q1	$452K	Buy
2021 Q4	$403K	Buy
2021 Q3	–	Sell
2021 Q2	$2.12M	Buy
2021 Q1	$575K	Buy
2020 Q4	$288K	Buy